Tonglian Animal Health

Tonglian Animal Health is the veterinary division of Shenyang Tonglian Group, a major Chinese pharmaceutical conglomerate specializing in the production of biochemical active pharmaceutical ingredients (APIs) and finished preparations. The company is a global leader in the manufacture of macrolide antibiotics, including tylosin and erythromycin, as well as penicillin industrial salts and vitamins. Utilizing large-scale fermentation facilities in Hulunbuir and advanced R&D centers in Shanghai and Shenyang, Tonglian provides essential anti-infective solutions for the livestock and poultry industries. The company is also notable for its parent group's development of Carrimycin, a novel genetically engineered macrolide antibiotic produced through synthetic biology. Tonglian's manufacturing capabilities are extensive, reportedly supplying a significant portion of the global demand for veterinary APIs. The company continues to leverage its expertise in fermentation and biotechnology to expand its portfolio of animal health products.